Companies

Carlyle sheds 13% stake in Metropolis Healthcare

Our Bureau Chennai | Updated on April 15, 2020 Published on April 15, 2020

Smallcap World Fund buys 10 lakh shares; other buyer’s name not known

CA Lotus Investments, an investment arm of Carlyle group, sold 65.51 lakh shares of Metropolis Healthcare through a bulk deal on the BSE. The offer size is 13.06 per cent of the outstanding share capital of Metropolis. Currently, CA Lotus holds 71.79 lakh shares or 14.31 per cent stake in the company.

CA Lotus sold 32.76 lakh shares and 32.75 lakh shares in two separate deals at average prices of ₹1,152.64 and ₹1,152.2 respectively. Of this, Smallcap World Fund bought 10 lakh shares. However, the name of the other buyer was not readily available.

The company had earlier fixed the floor price of the issue at ₹1,110 a share, which is a 17 per cent discount to the last closing share price of Metropolis on Monday at ₹1,337.55. Following this, the stock price of Metropolis crashed 14 per cent to ₹1,152.5 in initial trades, but bounced back after the the deal was executed.

The stock, on Wednesday, finally closed at ₹1,258.96, down 6.3 per cent, over the previous day’s close.

It may be recalled that the PE firm sold 74.12 lakh shares through Metropolis Healthcare’s IPO that had hit the market last April. Through the sale, Carlyle had raised about ₹650 crore.

The PE firm had acquired the stake in 2015 by buying out GSK Velu, the former co-promoter of Metropolis.

Published on April 15, 2020

A letter from the Editor


Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.